Alnylam gets orphan status for hemophilia A
August 20, 2013 at 14:06 PM EDT
A week after one of its gene-based potential drugs was given orphan drug designation for hemophilia B, Alnylam Pharmaceuticals Inc...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.